Publications by authors named "Adele Rowley"

Claim this Profile
A
A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease.
Mike Taylor, George Ousler, Gail Torkildsen, Claire Walshe, Matthew C T Fyfe, Adele Rowley

Clin Ophthalmol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Narrow Spectrum Kinase Inhibitors Demonstrate Promise for the Treatment of Dry Eye Disease and Other Ocular Inflammatory Disorders.
Suzanne Hagan, Matthew C T Fyfe, Boatemaa Ofori-Frimpong, Katherine Oliver, Martyn R Foster, Adele Rowley

Invest Ophthalmol Vis Sci· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Narrow Spectrum Versus Selective Kinase Inhibitors on the Intestinal Proinflammatory Immune Response in Ulcerative Colitis.
Paolo Biancheri, Martyn R Foster, Matthew C T Fyfe, Thomas T MacDonald, Sameer Sirohi, Adele Rowley

Inflamm Bowel Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
γ -Secretase Pharmacology: What Pharmacology Will Work for Alzheimer's Disease?
Jeremy H Toyn, Adele Rowley, Yasuji Matsuoka, Taisuke Tomita, Bruno P Imbimbo

Int J Alzheimers Dis· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis